farnesol and miconazole

farnesol has been researched along with miconazole in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Prasad, R; Sharma, M	1
Delvenne, P; Hermanns-Lê, T; Piérard, GE; Piérard-Franchimont, C	1
Borges de Menezes Leite, L; Correa Amaral, A; Evangelista Araujo, D; Fernandes Costa, A; Pereira, M; Santos Cabral, M; Teles Brito, I	1

Reviews

1 review(s) available for farnesol and miconazole

Article	Year
Miconazole, a pharmacological barrier to skin fungal infections. Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:8 Topics: Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Ergosterol; Farnesol; Fungi; Humans; Hydrogen Peroxide; Miconazole	2012

Other Studies

2 other study(ies) available for farnesol and miconazole

Article	Year
The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10 Topics: Amphotericin B; Antifungal Agents; Apoptosis; ATP-Binding Cassette Transporters; Biological Transport, Active; Candida albicans; Drug Resistance, Multiple, Fungal; Drug Synergism; Farnesol; Fluconazole; Fungal Proteins; Ketoconazole; Kinetics; Membrane Transport Proteins; Miconazole; Microbial Sensitivity Tests; Quorum Sensing; Reactive Oxygen Species; Rhodamines; Saccharomyces cerevisiae	2011
Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis. Medical mycology, 2019, Jan-01, Volume: 57, Issue:1 Topics: Animals; Antifungal Agents; BALB 3T3 Cells; Candida albicans; Candidiasis, Vulvovaginal; Capsules; Chitosan; Disease Models, Animal; Farnesol; Female; Mice; Mice, Inbred BALB C; Miconazole; Microbial Sensitivity Tests; Microbial Viability; Nanoparticles	2019

Article

Year

The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.

Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

Topics: Amphotericin B; Antifungal Agents; Apoptosis; ATP-Binding Cassette Transporters; Biological Transport, Active; Candida albicans; Drug Resistance, Multiple, Fungal; Drug Synergism; Farnesol; Fluconazole; Fungal Proteins; Ketoconazole; Kinetics; Membrane Transport Proteins; Miconazole; Microbial Sensitivity Tests; Quorum Sensing; Reactive Oxygen Species; Rhodamines; Saccharomyces cerevisiae

2011

Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis.

Medical mycology, 2019, Jan-01, Volume: 57, Issue:1

Topics: Animals; Antifungal Agents; BALB 3T3 Cells; Candida albicans; Candidiasis, Vulvovaginal; Capsules; Chitosan; Disease Models, Animal; Farnesol; Female; Mice; Mice, Inbred BALB C; Miconazole; Microbial Sensitivity Tests; Microbial Viability; Nanoparticles

2019